2 results
Approved WMOCompleted
To determine if there is a difference in the pharmacokinetics of low-dose cisplatin with and without prehydration.
Approved WMOCompleted
Primary: To characterize the safety and tolerability of PDR001 in combination with LCL161, everolimus, HDM201, QBM076 or panobinostat and to identify recommended doses and schedules for future studies.Secondary: To characterize changes in the immune…